| 
			Prime Minister Prayuth Chan-ocha, the former junta leader who heads 
			a civilian government following March elections, is due to set out 
			the policies for debate in the national assembly on Thursday. The 
			policy document was released on Sunday.
 Developing the medical cannabis industry was a key demand of the 
			Bhumjaithai party, one of the biggest parties in Prayuth's 19-party 
			coalition.
 
 "The study and technological development of marijuana, hemp, and 
			other medicinal herbs should be sped up for the medical industry to 
			create economic opportunity and income for the people," the policy 
			document said.
 
 Thailand, which had a tradition of using cannabis to relieve pain 
			and fatigue, legalized marijuana for medical use and research last 
			year.
 
 Bhumjaithai party leader Anutin Charnvirakul, now a deputy prime 
			minister and health minister, said his goal was to enable all Thais 
			to grow marijuana to make money.
 
 
 
			
            [to top of second column] | 
            
			 
			Anutin told local media it was important to remove hemp with a high 
			level of cannabidiol (CBD) from the list of banned drugs for 
			cultivation and then to free up hospitals to prescribe drugs 
			containing the chemical compound.
 Among other urgent government priorities were addressing drought, 
			labor and economic problems.
 
 Also on the list was a study to amend a new constitution that 
			critics say preserves the hold of the military indefinitely. This 
			study had been a demand of another coalition partner, the Democrat 
			Party.
 
 However, any constitutional changes would require the support of the 
			Senate - which is entirely made up of appointees of the previous 
			junta.
 
 (Reporting by Panu Wongcha-um and Panarat Thepgumpanat; Editing by 
			Matthew Tostevin and Michael Perry)
 
			[© 2019 Thomson Reuters. All rights 
				reserved.] Copyright 2019 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed.  
			Thompson Reuters is solely responsible for this content. |